Patent directory · USPTO A61K / A61P
Patents matching “Ionis Pharmaceuticals, Inc.”
202 pharma patents match "Ionis Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 202 pharmaceutical patents matching "Ionis Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9957504
Compositions and methods for modulating apolipoprotein (a) expression
granted -
US 9957292
Compositions and methods for modulating angiopoietin-like 3 expression
granted -
US 9943539
2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations
granted -
US 9943604
Targeted therapeutic nucleosides and their use
granted -
US 9943538
2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations
granted -
US 9932581
Compositions and methods for modulating apolipoprotein C-III expression
granted -
US 9932580
Compositions and methods for modulating HBV expression
granted -
US 9920321
Compositions and their uses directed to huntingtin
granted -
US 9909124
Compounds and methods for modulating apolipoprotein C-III expression for improving a diabetic profile
granted -
US 9885047
Modulation of TMPRSS6 expression
granted -
US 9885045
Methods and compositions for modulating apolipoprotein (a) expression
granted -
US 9884072
Methods and compositions for modulating apolipoprotein (a) expression
granted -
US 9873876
Cancer treatment
granted -
US 9827263
2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations
granted -
US 9816092
Modulation of transthyretin expression
granted -
US 9796976
Methods and compositions for modulating alpha-1 antitrypsin expression
granted -
US 9765338
Modulation of dystrophia myotonica-protein kinase (DMPK) expression
granted -
US 9725722
Modulation of TMPRSS6 expression
granted -
US 9714421
Compositions and methods
granted -
US 9708610
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
granted -
US 9695475
Competitive modulation of microRNAs
granted -
US 9688987
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
granted -
US 9683235
Compositions for modulating Tau expression
granted -
US 9683236
Modulation of huntingtin expression
granted